$ALLO
Allogene Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.70
▼-1.76%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAllogene Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ALLO down today? It is at $1.70 (-1.76%), and our scanner flagged it 81 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALLO spikes, and full due diligence on ALLO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALLO 81 times in the last 30 days. Create a free account to track $ALLO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ALLO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALLO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Douglas Earl Martin Officer | Sold (automatic/other) | -30K | sold 5.7% | 488K | $63K at $2.12 | Aug 21, 26 |
Kazam Joshua A Director | Other | 48K 0.01% of company | added 14% | 398K | n/a | Jun 18, 26 |
Yoshiyama Annie Officer | Sold (automatic/other) | -10K | sold 7.1% | 125K | $22K at $2.31 | Apr 21, 26 |
Beneski Benjamin Machinas Officer | Sold (automatic/other) | -3K | sold 1.4% | 195K | $7K at $2.50 | Mar 31, 26 |
Chang David D Officer | Sold (automatic/other) | -48K 0.01% of company | sold 0.9% | 5.15M | $118K at $2.47 | Mar 16, 26 |
Beneski Benjamin Machinas Officer | Sold (automatic/other) | -5K | sold 2.4% | 198K | $12K at $2.47 | Mar 16, 26 |
Beneski Benjamin Machinas Officer | Sold (automatic/other) | -7K | sold 3.4% | 203K | $19K at $2.60 | Mar 2, 26 |
Roberts Zachary Officer | Sold (automatic/other) | -36K 0.01% of company | sold 5.8% | 581K | $63K at $1.77 | Feb 2, 26 |
Yoshiyama Annie Officer | Sold (automatic/other) | -4K | sold 3.1% | 130K | $7K at $1.72 | Feb 2, 26 |
Douglas Earl Martin Officer | Sold (automatic/other) | -23K | sold 3.9% | 565K | $40K at $1.76 | Feb 2, 26 |
Parker Geoffrey M. Officer | Sold (automatic/other) | -24K | sold 1.9% | 1.25M | $42K at $1.76 | Feb 2, 26 |
Chang David D Officer | Sold (automatic/other) | -95K 0.03% of company | sold 1.8% | 5.19M | $171K at $1.80 | Feb 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ALLO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALLO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ALLO last traded at $1.70, down 1.76% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Allogene Therapeutics, Inc. Common Stock (ALLO) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ALLO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALLO 81 times in the last 30 days.
ALLO (Allogene Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $584M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALLO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALLO discussion
Sign in to ask a question or join the discussion.